30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Spine Company 510(k)s from 1H16: Newcomers Aren’t All at NASS

In 1H16, 21 companies received their first orthopaedic-related 510(k). Of these, ten were bestowed for spinal products. Of those ten companies, only four are slated to appear on the NASS floor this year.

Growth Strategies in Action: Leaders in Spine

In observing the lineup of spine revenue over $100 million halfway through the year, NuVasive stands at the forefront of growth while pure-play companies like Globus and K2M are outperforming their diversified peers in the field.

Company Revenue Update, 1H16

This summary of 2Q16 orthopaedic revenue includes exhibits depicting where these companies stood at the half. 

Medtronic Company Profile

Revenue derived from spine and orthobiologics positions Medtronic as the fifth-largest in the orthopaedic industry. The company achieved sales of $2.9 billion in 2015.

NASS Preview: NASS Survey Finds Spine Professionals Independent and Influencing Decisions

In 2015, NASS conducted a survey taken by nearly 650 Members in the U.S. to support a clearer understanding of its Members’ practice settings.

Page Navigation